Suppr超能文献

降低住院高钾血症患者胰岛素治疗后低血糖的发生。

Decreasing Hypoglycemia following Insulin Administration for Inpatient Hyperkalemia.

机构信息

School of Pharmacy, University of California, San Francisco, California

Division of Endocrinology and Metabolism, University of California, San Francisco, California

出版信息

J Hosp Med. 2020 Feb;15(2):368-370. doi: 10.12788/jhm.3357.

Abstract

BACKGROUND

Acute hyperkalemia (serum potassium ≥ 5.1 mEq/L) is often treated with a bolus of IV insulin. This treatment may result in iatrogenic hypoglycemia (glucose < 70 mg/dl).

OBJECTIVES

The aims of this study were to accurately determine the frequency of iatrogenic hypoglycemia following insulin treatment for hyperkalemia, and to develop an electronic health record (EHR) orderset to decrease the risk for iatrogenic hypoglycemia.

DESIGN

This study was an observational, prospective study.

SETTING

The setting for this study was a university hospital.

PATIENTS

All nonobstetric adult inpatients in all acute and intensive care units were eligible.

INTERVENTION

Implementation of a hyperkalemia orderset (Orderset 1.1) with glucose checks before and then one, two, four, and six hours after regular intravenous insulin administration. Based on the results from Orderset 1.1, Orderset 1.2 was developed and introduced to include weight-based dosing of insulin options, alerts identifying patients at higher risk of hypoglycemia, and tools to guide decision-making based on the preinsulin blood glucose level.

MEASUREMENTS

Patient demographics, weight, diabetes history, potassium level, renal function, and glucose levels were recorded before, and then glucose levels were measured again at one, two, four, and six hours after insulin was administered.

RESULTS

The iatrogenic hypoglycemia rate identified with mandatory glucose checks in Orderset 1.1 was 21%; 92% of these occurred within three hours posttreatment. Risk factors for hypoglycemia included decreased renal function (serum creatinine >2.5 mg/dl), a high dose of insulin (>0.14 units/kg), and re-treatment with blood glucose < 140 mg/dl. After the introduction of Orderset 1.2, the rate of iatrogenic hypoglycemia decreased to 10%.

CONCLUSIONS

The use of an EHR orderset for treating hyperkalemia may reduce the risk of iatrogenic hypoglycemia in patients receiving insulin while still adequately lowering their potassium.

摘要

背景

急性高钾血症(血清钾≥5.1mEq/L)常采用静脉推注胰岛素治疗。这种治疗可能导致医源性低血糖(血糖<70mg/dl)。

目的

本研究旨在准确确定治疗高钾血症时使用胰岛素后医源性低血糖的发生频率,并开发电子病历(EHR)医嘱集以降低医源性低血糖的风险。

设计

本研究为观察性前瞻性研究。

设置

本研究地点为一所大学医院。

患者

所有非产科成年住院患者,包括所有急症和重症监护病房的患者。

干预措施

实施高钾血症医嘱集(医嘱集 1.1),在常规静脉推注胰岛素前后、1 小时、2 小时、4 小时和 6 小时进行血糖检查。根据医嘱集 1.1 的结果,开发并引入医嘱集 1.2,包括基于体重的胰岛素剂量选择、识别低血糖风险较高的患者的警报,以及根据胰岛素前血糖水平指导决策的工具。

测量

记录患者的人口统计学、体重、糖尿病史、血钾水平、肾功能和血糖水平,然后在胰岛素给药后 1 小时、2 小时、4 小时和 6 小时再次测量血糖水平。

结果

医嘱集 1.1 中强制血糖检查发现的医源性低血糖发生率为 21%;92%的低血糖发生在治疗后 3 小时内。低血糖的危险因素包括肾功能下降(血清肌酐>2.5mg/dl)、胰岛素剂量较高(>0.14 单位/公斤)和血糖<140mg/dl 时再次治疗。引入医嘱集 1.2 后,医源性低血糖发生率降至 10%。

结论

使用 EHR 医嘱集治疗高钾血症可能会降低接受胰岛素治疗的患者发生医源性低血糖的风险,同时仍能有效降低血钾水平。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验